Hardy John, Lees Andrew J
Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
Mov Disord. 2005 Aug;20 Suppl 12:S2-4. doi: 10.1002/mds.20532.
Parkinson's disease (PD) is a clinical diagnosis. We argue here that if we are to make progress in understanding its underlying pathogenesis, there is a need to have a pathological definition of disease that includes the presence of Lewy bodies and nigral loss in the ventrolateral tier of the pars compacta of the substantia nigra. Using such a definition, there is only one certain and known cause: mutations in the alpha-synuclein gene. However, the phenotype of this one known cause is broader than PD and encompasses Lewy body dementia.
帕金森病(PD)是一种临床诊断。我们在此认为,如果要在理解其潜在发病机制方面取得进展,就需要对疾病有一个病理学定义,该定义应包括路易小体的存在以及黑质致密部腹外侧层的黑质神经元缺失。采用这样的定义,只有一个确定且已知的病因:α-突触核蛋白基因突变。然而,这一已知病因的表型比帕金森病更广泛,还包括路易体痴呆。